Aspire Ftd
1 known investors
AviadoBio is a biotech company developing gene therapies for neurodegenerative diseases, starting with frontotemporal dementia. This page describes ASPIRE-FTD, a Phase 1/2 clinical trial evaluating AVB-101, a one-time gene therapy delivered surgically to the thalamus for patients with FTD-GRN mutations, conducted at neurosurgical centers in Europe and the United States.
Investors · 1
Frequently asked questions
- What does Aspire Ftd do?
- AviadoBio is a biotech company developing gene therapies for neurodegenerative diseases, starting with frontotemporal dementia. This page describes ASPIRE-FTD, a Phase 1/2 clinical trial evaluating AVB-101, a one-time gene therapy delivered surgically to the thalamus for patients with FTD-GRN mutations, conducted at neurosurgical centers in Europe and the United States.
- Who are Aspire Ftd's investors?
- Aspire Ftd's investors include Advent Life Sciences.